Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
222.34
324.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Shenzhen Mindray Bio-Medical Electronics Co Ltd
Shenzhen Mindray Bio-Medical Electronics Co Ltd
Total Liabilities
Shenzhen Mindray Bio-Medical Electronics Co Ltd
Total Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Total Liabilities
¥21.8B
|
CAGR 3-Years
30%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Total Liabilities
¥665.8m
|
CAGR 3-Years
73%
|
CAGR 5-Years
64%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Total Liabilities
¥3.5B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
20%
|
CAGR 10-Years
24%
|
|
|
J
|
Jafron Biomedical Co Ltd
SZSE:300529
|
Total Liabilities
¥2.4B
|
CAGR 3-Years
23%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
|
|
L
|
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
|
Total Liabilities
¥9.4B
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
39%
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Total Liabilities
¥6.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
Glance View
In the bustling city of Shenzhen, China, a thriving enterprise known as Shenzhen Mindray Bio-Medical Electronics Co., Ltd, has cemented its place within the global medical devices market. Born in 1991 amid the backdrop of China’s rapid economic expansion, Mindray embarked on an ambitious journey to revolutionize healthcare technology. The company operates across three main segments: patient monitoring and life support, in-vitro diagnostics, and medical imaging systems. Each category is crucial to the medical infrastructure, with patient monitoring systems tracking vital statistics in real-time, in-vitro diagnostics facilitating intricate lab testing, and medical imaging enabling precise internal examinations. The synergy among these segments allows Mindray to deliver comprehensive solutions that enhance both the quality and efficiency of healthcare systems worldwide. Mindray's business model is intrinsically tied to innovation and global distribution. The company continually invests in research and development, a strategic move that keeps it at the forefront of medical technology advancement. Its R&D centers — strategically located in China, the U.S., and Europe — work tirelessly to push the boundaries of medical technology and address the evolving needs of healthcare professionals. In tandem with its technological prowess, Mindray crafts a robust network of distribution that ensures its advanced devices reach hospitals and clinics across over 190 countries. This expansive market presence, coupled with competitive pricing strategies, has propelled the company to secure a formidable foothold in both emerging and developed economies, thereby transforming the accessibility and delivery of healthcare services on a global scale.
See Also
What is Shenzhen Mindray Bio-Medical Electronics Co Ltd's Total Liabilities?
Total Liabilities
21.8B
CNY
Based on the financial report for Sep 30, 2024, Shenzhen Mindray Bio-Medical Electronics Co Ltd's Total Liabilities amounts to 21.8B CNY.
What is Shenzhen Mindray Bio-Medical Electronics Co Ltd's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
26%
Over the last year, the Total Liabilities growth was 65%. The average annual Total Liabilities growth rates for Shenzhen Mindray Bio-Medical Electronics Co Ltd have been 30% over the past three years , 26% over the past five years .
You don't have any saved screeners yet
